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Hospital-Based Acute Care Use in Survivors of Septic Shock
Abstract
OBJECTIVES: Septic shock is associated with increased long-term morbidity and mortality. However, little is
known about the use of hospital-based acute care in survivors after hospital discharge. The objectives of the
study were to examine the frequency, timing, causes, and risk factors associated with emergency department
visits and hospital readmissions within 30 days of discharge.
DESIGN: Retrospective cohort study.
SETTING: Tertiary, academic hospital in the United States.
PATIENTS: Patients admitted with septic shock (serum lactate ≥ 4 mmol/L or refractory hypotension) and
discharged alive to a nonhospice setting between 2007 and 2010.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: The coprimary outcomes were all-cause hospital readmission
and emergency department visits (treat-and-release encounters) within 30 days to any of the three health
system hospitals. Of 269 at-risk survivors, 63 (23.4%; 95% CI, 18.2-28.5) were readmitted within 30 days of
discharge and another 12 (4.5%; 95% CI, 2.3-7.7) returned to the emergency department for a treat-and-
release visit. Readmissions occurred within 15 days of discharge in 75% of cases and were more likely in
oncology patients (p=0.001) and patients with a longer hospital length of stay (p=0.04). Readmissions were
frequently due to another life-threatening condition and resulted in death or discharge to hospice in 16% of
cases. The reasons for readmission were deemed potentially related to the index septic shock hospitalization in
78% (49 of 63) of cases. The most common cause was infection related, accounting for 46% of all 30-day
readmissions, followed by cardiovascular or thromboembolic events (18%).
CONCLUSIONS: The use of hospital-based acute care appeared to be common in septic shock survivors.
Encounters often led to readmission within 15 days of discharge, were frequently due to another acute
condition, and appeared to result in substantial morbidity and mortality. Given the potential public health
implications of these findings, validation studies are needed.
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cohort studies, emergency service, hospital, female, humans, length of stay, male, middle aged, patient
readmission, retrospective studies, shock, septic, United States
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Abstract
Objective—Septic shock is associated with increased long-term morbidity and mortality. 
However, little is known about the use of hospital-based acute care in survivors after hospital 
discharge. The objectives of the study were to examine the frequency, timing, causes, and risk 
factors associated with Emergency Department (ED) visits and hospital readmissions within 30 
days of discharge.
Design—Retrospective cohort study.
Setting—Tertiary, academic hospital in the United States.
Patients—Patients admitted with septic shock (serum lactate ≥ 4 mmol/L or refractory 
hypotension) and discharged alive to a non-hospice setting between 2007 and 2010.
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Interventions—None.
Measurements and Main Results—The co-primary outcomes were all-cause hospital 
readmission and ED visits (treat-and-release encounters) within 30 days to any of the three health 
system hospitals. Of 269 at-risk survivors, 63 (23.4%, 95% confidence interval (CI): 18.2, 28.5) 
were readmitted within 30 days of discharge and another 12 (4.5%, 95% CI: 2.3, 7.7) returned to 
the ED for a treat-and-release visit. Readmissions occurred within 15 days of discharge in 75% of 
cases and were more likely in oncology patients (p=0.001) and patients with a longer hospital 
length of stay (p=0.04). Readmissions were frequently due to another life-threatening condition 
and resulted in death or discharge to hospice in 16% of cases. The reasons for readmission were 
deemed potentially related to the index septic shock hospitalization in 78% (49/63) of cases. The 
most common cause was infection-related, accounting for 46% of all 30-day readmissions, 
followed by cardiovascular or thromboembolic events (18%).
Conclusions—The use of hospital-based acute care appeared to be common in septic shock 
survivors. Encounters often led to readmission within 15 days of discharge, were frequently due to 
another acute condition, and appeared to result in substantial morbidity and mortality. Given the 
potential public health implications of these findings, validation studies are needed.
Keywords
septic shock; infection; hospital readmission; emergency department use
Sepsis has a tremendous impact on our health care system. The incidence of sepsis in the 
U.S. has been rising (1) and the associated cost has been estimated at $24.3 billion (2). 
Although the incidence has increased, substantially more patients are surviving their 
hospitalization (1, 3–8).
Sepsis survivorship is associated with cognitive and physical impairments, decreased quality 
of life, and increased long-term mortality (9–13). While evidence has highlighted the 
importance of understanding the trajectories of care after critical illness (14), little is known 
about the healthcare needs of septic shock survivors. Hospital-based, acute care use after a 
hospitalization is common and costly (15–17). Emergency department (ED) visits and 
hospital readmissions may reflect the quality and coordination of care provided during the 
index hospitalization (15–20). To patients and family members, these are important and 
stressful events that can disrupt the recovery process (21). Recent studies using 
administrative data have shown that sepsis survivors may be particularly vulnerable (22–24). 
Therefore, urgent investigation is justified to determine how often these events occur and, 
importantly, why.
We evaluated septic shock survivors, defined by several recent clinical trials as a serum 
lactate level of 4 mmol/L or higher or refractory hypotension (5–7), to determine the 
frequency, timing, and causes of ED visits and hospital readmissions. We hypothesized that 
hospital-based acute care use in the 30 days following a hospitalization for septic shock 
would be common, occurring in one in five cases or more based on other high-risk 
conditions (15–17), and the reasons for and outcomes related to these encounters may 
explain the increased mortality that survivors experience.
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Materials and Methods
Study Design
This was a retrospective cohort study of adult survivors of septic shock discharged between 
December, 2007 and January, 2010. The institutional review board of the University of 
Pennsylvania approved the study (#819400) with an informed consent exemption.
Study Setting and Population
We conducted the study at the Hospital of the University of Pennsylvania (HUP), a tertiary 
care university hospital within the three hospital University of Pennsylvania Health System 
(UPHS). We studied patients admitted from the ED with septic shock, defined as a serum 
lactate level ≥4 mmol/L or systolic blood pressure <90 mm Hg after volume resuscitation or 
use of a vasoactive agent (5–7). The details of our validated strategy to identify cases of 
severe sepsis and quality assurance have been described previously (25–28). To examine 
hospital-based, acute care use in survivors and maintain the assumption of independent 
observations, we limited the study to patients discharged to a non-hospice setting after an 
index septic shock admission. We excluded patients who did not fulfill criteria for septic 
shock (29–30) and those who left against medical advice (AMA) or were transferred to 
another institution.
Data Collection
As part of the HUP Severe Sepsis database, trained investigators collected ED and 
hospitalization data from the electronic medical record (EMR) using a pre-drafted case 
abstraction form (25–28), permitting calculation of the Charlson Comorbidity Index (31). 
Consistent with prior work (25), missing data (>5% per variable) was rare and limited to 
laboratory measurements (e.g., coagulation measures). The Acute Physiology and Chronic 
Health Evaluation (APACHE) II score was calculated at hospital admission (25, 32).
We abstracted the following from the EMR using a separate abstraction form to examine 
hospital-based, acute care use within UPHS: disposition and follow-up at discharge from the 
index hospitalization, prior hospitalization within 30 days of the index hospitalization, and 
dates, timing, cause, and outcome of an ED encounter and/or hospital readmission within 30 
days (33). We identified readmissions occurring after 30 days to calculate 60- and 90-day 
readmission rates. We did not collect data on ED visits or readmissions outside of UPHS, 
nor did we abstract data on subsequent ED visit(s) or readmission(s), with the exception of 
ED encounters that led to readmission. Consistent with the parent registry (25), post-
discharge data was verified by a separate investigator for accuracy.
Our co-primary outcomes were ED visits (treat-and-release) and all-cause hospital 
readmission to any UPHS hospital within 30 days of discharge after the index 
hospitalization for septic shock (15–17). We included patients readmitted via inter-hospital 
transfer to minimize the risk of underestimating the hospital readmission rate. As a 
reference, using 2010 administrative data, we calculated the 30-day readmission rate for 
10,985 index medical and surgical admissions at HUP to be 13.4% (95% confidence interval 
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(CI): 12.8, 14.1). Secondary outcomes included 60- and 90-day hospital readmission rate 
and a composite outcome of ED visit and hospital readmission within 30 days of discharge.
A focus of the study was to understand why survivors returned to the hospital. Consistent 
with the readmission literature (34–35), we considered a 30-day readmission to be 
potentially related to the index septic shock admission when the readmission was due to an 
unresolved, recurrent, or new infection or was due to a clinical deterioration or complication 
potentially related to care provided or a consequence of sepsis. We a priori categorized 
readmissions as related to: acute kidney injury, cognitive impairment (e.g., medication 
error), complications of tubes and lines, cardiovascular and thromboembolic events, 
infection, physical impairment (e.g., falls), and when the readmission was potentially related 
to the index septic shock admission but not captured in the above categories, as other (9–13, 
36–44). When the readmission was attributed exclusively to the underlying disease and/or 
was elective, it was deemed unavoidable.
Two independent investigators reviewed the discharge summary, including primary and 
secondary diagnoses, and EMR to determine the readmission cause. Due to the infrequent 
number of readmissions attributed to cognitive and physical impairment, these were 
collapsed into the other category, resulting in 6 final response options. The inter-rater 
reliability for diagnoses was good, with a Kappa statistic of 0.79 (95% confidence interval 
(CI): 0.67 – 0.92). Adjudication, necessary for 9 readmissions, was performed by a third 
investigator blinded to prior assessments. The cause of an ED treat-and-release visit was 
determined by its ICD-9 code.
Last, we examined the relationship between clinical risk factors and 30-day hospital 
readmission. Using the general readmission (33–35) and sepsis literature, we examined 
sociodemographics, comorbid conditions, illness severity at presentation and during the 
hospitalization, source of sepsis, hospital length of stay, and discharge disposition. To assess 
whether hospital readmission was associated with quality of care provided at presentation, 
we tested time to antibiotics (27), volume of resuscitation (5–7), and initiation of early goal-
directed therapy (5–7, 26). We considered year of admission and prior hospitalization within 
30 days of the index hospitalization as potential confounders (28, 34).
Statistical Analyses
We compared continuous variables across groups using Student’s t-test or Wilcoxon’s rank-
sum test and compared categorical variables across groups using the chi-squared test or 
Fisher’s exact test, as appropriate. We used Stata 13.0 IC (Stata Datacorp, College Station, 
TX) to perform analyses and considered p-values ≤ 0.05 as significant.
We used multivariable logistic regression to adjust for potential confounding in the 
associations between risk factors and 30-day hospital readmission. In primary analyses, 
factors associated with the dependent variable at a significance level of p<0.05 in bivariate 
analyses were included to create parsimonious multivariable models. Potential confounding 
variables associated at a significance level of p<0.20 were added one-at-a-time to the base 
model and maintained if there was an alteration by >10% in the point estimate for the odds 
ratio (OR) of any risk factor (45). Multicollinearity was assessed using variance inflation 
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factors. In primary analyses, we excluded variables with ≤10 observations per cell to avoid 
overfitting. In secondary analyses, we included these variables one-at-a-time. In separate 
secondary analyses, we included factors associated with the dependent variable at a 
significance level of p<0.20 in bivariate analyses into the multivariable models.
Results
Baseline characteristics
Of 997 unique severe sepsis patients over the study interval, we examined 414 patients 
admitted from the ED with septic shock. Of these 414 patients, 23.2% expired in-hospital 
and 8.7% were discharged to hospice (see Figure 1). After excluding 13 survivors who left 
AMA or were transferred, there were 269 survivors at-risk for hospital readmission (Table 
1).
Rate, Timing, and Cause of 30-Day Emergency Department Visits and 30-Day Readmission
Of 269 at-risk survivors, 63 (23.4%, 95% CI: 18.2, 28.5) were readmitted within 30 days 
and another 12 (4.5%, 95% CI: 2.3, 7.7) returned to the ED for a treat-and-release visit 
(readmission rates presented in Table 2). The median time to an ED encounter was 8 days, 
with interquartile range (IQR) from 4 to 15 days. Of the 56 ED encounters within 30 days, 
the conversion rate to hospital admission was 75% (42/56). The reasons for a treat-and-
release ED visit varied, with the most common reasons being infection (n=6), device 
complications (n=3) and fall injuries (n=2) (see Table 2).
The majority of 30-day readmissions presented to UPHS through the ED (68%), with the 
remainder presenting as a direct admission (24%) or outside hospital transfer (8%). The 
median time to 30-day hospital readmission was 7 days, IQR: 3, 15 (Figure 2) and the 
median length of stay for readmissions was 5 days, IQR: 2, 14. Of 30-day readmissions, 21 
(33%) survivors required ICU care and 10 (16%) expired or were transitioned to hospice 
during the readmission. Follow-up appointments were not arranged for 26 readmitted 
patients, and 17 were readmitted prior to their scheduled follow-up.
The reasons for readmission were potentially related to the index septic shock 
hospitalization in 78% (49/63) of cases (Table 3). The most common cause was infection, 
accounting for 46% of 30-day readmissions, followed by cardiovascular or thromboembolic 
at 18%. The infectious causes for readmission varied, with cellulitis and soft tissue 
infections being the most common (28%), followed by pneumonia (24%), gastrointestinal 
infections (17%), and bacteremia (17%).
Characteristics of Patients Readmitted Within 30 Days
Compared to those not readmitted, readmitted patients were more likely to have been 
hospitalized within the prior 30 days of the index septic shock hospitalization (p<0.001), 
have cirrhosis (p=0.05), an oncology diagnosis (p<0.001), lower initial serum lactate levels 
(p=0.02), higher APACHE II scores (p=0.05), longer hospital lengths of stay (p=0.01), and 
were more likely to be discharged with a PICC (p=0.02) (Table 4). Although readmitted 
patients had more comorbidities as measured by the Charlson (p=0.001), the association was 
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non-significant when the oncology subscore was removed (p=0.67). There were no 
significant differences between the two groups in ED quality measures, other metrics of 
illness severity, or admission year (p=0.46).
In multivariable models, independent risk factors associated with 30-day hospital 
readmission included: an oncology diagnosis (p=0.001), hospitalization within 30 days of 
the index septic shock hospitalization (p=0.01), and length of stay (p=0.04) (Table 5). Initial 
serum lactate levels were collinear with APACHE II scores. Neither initial lactate levels 
(p=0.07), nor APACHE II when substituted for lactate levels in multivariable models 
(p=0.58), were associated with 30-day readmission. In secondary analyses including 
variables with ≤10 observations per cell, cirrhosis was independently associated with 30-
dayreadmission (p=0.04). In separate secondary analyses, including discharge disposition, 
use of mechanical ventilation, and coagulation failure as variables associated with the 
dependent variable at a less conservative significance level, an oncology diagnosis 
(p=0.001) and a hospitalization within 30 days of the index septic shock hospitalization 
(p=0.02) were the lone factors associated with 30-day readmission.
Discussion
In this observational study of survivors of septic shock, our principal finding was that there 
was a high rate of hospital-based acute care use among patients discharged after an 
admission for septic shock. Three-quarters of hospital-based, acute care occurred within 15 
days of discharge and these encounters often led to readmission. In sum, we found that 23% 
of at-risk survivors were readmitted within 30 days, substantially higher than the general 30-
day readmission rate at HUP, and nearly one out of six readmissions resulted in death or a 
transition to hospice. Furthermore, an additional 5% returned to the ED for a treat-and-
release visit.
These findings support and complement the recent findings of Liu et al (23) and Prescott et 
al (24). Using a claims-based approach to identify cases of sepsis at an integrated 
community-based healthcare system, Liu et al observed that 18% of sepsis survivors were 
rehospitalized within 30 days, with a median time to readmission of 11 days. The rate of 
readmission was observed to be as high as 22% in survivors in the highest predicted 
mortality quartile (23). In a separate claims-based investigation, Prescott et al. examined the 
post-discharge healthcare use of elderly survivors of severe sepsis within a longitudinal 
cohort (1998–2005) study. Using a design that would result in a slightly higher rate of 
readmission (i.e., repeat severe sepsis hospitalizations were included), Prescott and 
colleagues reported a rate of 30- and 90-day readmission rate of 26% and 41%, respectively, 
after a severe sepsis hospitalization (24). Survivors, in comparison to their pre-sepsis state 
and matched non-sepsis hospitalizations, experienced a substantial increase in healthcare use 
and greater post-discharge mortality in the year post-discharge (24).
Collectively, these findings suggest that sepsis survivors are a high-risk group that 
frequently requires hospital-based acute care after discharge. Importantly, whether these 
apparent risks are concentrated in the most severely ill survivors remains unclear. 
Nevertheless, the rate and pattern observed in these studies mirrors those seen in 
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readmissions after heart failure, acute myocardial infarction, and pneumonia (33). While it is 
possible that high-quality discharge planning and short-term follow-up after discharge could 
play a substantial role in lowering the rate of readmissions after sepsis (46), two critical 
questions require examination to focus efforts: who is at risk to be readmitted and why?
Consistent with Liu et al (23), we found that a higher burden of comorbid conditions and a 
lengthy hospitalization, as a measure of illness severity, were associated with readmission. 
Specifically, and in line with hospital readmissions in general (33–35), we found that an 
oncologic diagnosis was both prevalent amongst septic shock survivors and independently 
associated with an increased risk of hospital readmission. Further, many septic shock 
survivors had been hospitalized prior to the index septic shock admission and this exposure 
was a risk factor for subsequent hospital readmission. Given evidence of a bidirectional 
relationship between cognitive and physical decline and an acute infectious insult (9, 47), 
further investigation is required to elucidate the role that hospital-based, acute care plays in 
the path to decline or recovery in survivors (48).
As to why survivors are readmitted, the initial suggestion that infection played a pivotal role 
emanated from a recent Healthcare Cost and Utilization Project (49). Therein, Sutton et al. 
reported that amongst hospital admissions with a primary or secondary diagnosis of 
septicemia, 16% of survivors were rehospitalized with the same condition and this scenario 
appeared to be increasing (46). More recently, while data was limited to 79% of 
readmissions, Liu et al found infection was the cause in 28–43% of cases (23). We found 
that septic shock survivors were frequently readmitted within 30 days with life-threatening 
conditions. Infections caused, or at least contributed to, readmission in 46% of cases. The 
source of infection varied, with a skin or soft-tissue infection or pneumonia accounting for 
approximately 50% of the infectious cases, and an additional 34% due to gastrointestinal 
infections or bacteremia. These observations complement the report by Liu et al (23), and 
are consistent with a small, recent study that suggested that infectious risk is increased in 
sepsis survivors (50). Additional common causes included cardiovascular and 
thromboembolic events and acute kidney injury. These findings, in concert with the 
available evidence (23–24), suggest that readmissions are the result of a synergistic process 
between pre-sepsis health conditions and sepsis-related sequelae. The latter influence, which 
requires direct examination, may be related to provisions of sepsis care or to residual organ 
dysfunction, new or progressive functional impairments, and/or the enduring 
immunosuppressive, inflammatory, and procoagulant response of sepsis (36–44).
Innovative interventions will be required to accelerate recovery and mitigate the apparent 
readmission risk amongst survivors. The optimal strategy will likely require a coordinated, 
comprehensive approach from diagnosis to discharge planning and follow-up. Components 
with the potential to reduce readmissions include an antibiotic stewardship program during 
the hospitalization and post-discharge (51–52), a longitudinal rehabilitation program to 
mitigate against functional impairments (53), early and frequent follow-up, and timely 
access to providers to effectively manage new conditions and complications (54). 
Comparative studies, designed to test the various potential strategies, will be essential.
Ortego et al. Page 7
Crit Care Med. Author manuscript; available in PMC 2016 April 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
There are several limitations to discuss. First, our study focused on septic shock patients 
admitted through the ED. Further studies, designed to examine the full spectrum of sepsis 
and those who develop sepsis during the hospitalization, are required to determine whether 
post-acute care needs are concentrated in the most severely ill. Second, while we designed 
our study to identify ED visits and hospital readmissions to any UPHS hospital and captured 
patients readmitted through inter-hospital transfer, we were unable to capture care provided 
outside of UPHS and therefore may have underestimated the rate of post-discharge resource 
utilization and ED visits specifically. Third, we did not fully account for the burden 
experienced by septic shock survivors. Future studies, designed to complement the recent 
work of Liu et al (23) and Prescott et al (24), will be necessary to more completely describe 
the survivor’s experience, utilization of services, and associated costs. Fourth, amongst the 
readmissions categorized as unavoidable, septic shock may have accelerated the decline. 
Therefore, our classification schema may have underestimated the deleterious effects of 
septic shock. Fifth, the risk factor analyses were limited by power and therefore the potential 
for a Type II error exists. Although we examined a multitude of factors at presentation and 
during the hospitalization, we acknowledge the threat of residual confounding and the 
potential for a Type I error. Additional study is warranted to examine factors (e.g., infectious 
source, provisions of care (e.g., duration of antibiotics, transfusions) associated with post-
acute care use at discharge and readmission and how discharge disposition may modify this 
relationship.
In conclusion, the use of hospital-based acute care appears to be common in septic shock 
survivors. Encounters often occurred within 15 days of discharge, frequently led to 
readmission with a life-threatening condition, and appeared to result in substantial morbidity 
and mortality. Further studies are necessary to validate these findings and to identify 
effective strategies to address the post-acute care needs of survivors.
Acknowledgments
Funding: The study was supported in part by National Institutes of Health, National Heart, Lung and Blood 
Institute (NIH NHLBI) Loan Repayment Program, Bethesda, MD
References
1. Gaieski DF, Edwards JM, Kallan MJ, et al. Benchmarking the Incidence and Mortality of Severe 
Sepsis in the United States. Crit Care Med. 2013; 41:1167–74. [PubMed: 23442987] 
2. Lagu T, Rothberg MB, Shieh MS, et al. Hospitalizations, costs, and outcomes of severe sepsis in the 
United States 2003 to 2007. Crit Care Med. 2012; 40:754–761. [PubMed: 21963582] 
3. Stevenson EK, Rubenstein AR, Radin GT, et al. Two decades of mortality trends among patients 
with severe sepsis: a comparative meta-analysis. Crit Care Med. 2014; 42(3):625–31. [PubMed: 
24201173] 
4. Kaukonen KM, Bailey M, Suzuki S, et al. Mortality related to severe sepsis and septic shock among 
critically ill patients in Australia and New Zealand, 2000–2012. JAMA. 201410.10001/jama.
2014.2637
5. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis 
and septic shock. N Engl J Med. 2001; 345:1368–1377. [PubMed: 11794169] 
6. Jones AE, Shapiro NI, Trzeciak S, et al. Lactate clearance vs central venous oxygen saturation as 
goals of early sepsis therapy: a randomized clinical trial. JAMA. 2010; 303:739–746. [PubMed: 
20179283] 
Ortego et al. Page 8
Crit Care Med. Author manuscript; available in PMC 2016 April 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
7. The ProCESS Investigators. A randomized trial of protocol-based care for early septic shock. New 
Engl J Med. 201410.1056/NEJMoa1401602
8. Iwashyna TJ, Cooke CR, Wunsch H, Kahn JM. Population burden of long-term survivorship after 
severe sepsis among older Americans. J Am Geriatr Soc. 2012; 60(6):1070–1077. [PubMed: 
22642542] 
9. Iwashyna TJ, Ely EW, Smith DM, et al. Long-term cognitive impairment and functional disability 
among survivors of severe sepsis. JAMA. 2010; 304(16):1787. [PubMed: 20978258] 
10. Winters BD, Eberlein M, Leung J, et al. Long-term mortality and quality of life in sepsis; A 
systematic review. Crit Care Med. 2010; 38(5):1276–1283. [PubMed: 20308885] 
11. Cuthbertson BH, Elders A, Hall S, et al. Mortality and quality of life in the five years after severe 
sepsis. Crit Care. 2013; 17(2):R70. [PubMed: 23587132] 
12. Karlsson S, Ruokonen E, Varpula T, et al. Long-term outcome and quality-adjusted life years after 
severe sepsis. Crit Care Med. 2009; 37(4):1268–1274. [PubMed: 19242321] 
13. Hofhuis JG, Spronk PE, van Stel HF, et al. The impact of severe sepsis on health-related quality of 
life: a long-term follow-up study. Anesth Analg. 2008; 107(6):1957–64. [PubMed: 19020144] 
14. Unroe M, Kahn JM, Carson SS, Govert JA, Martinu T, Sathy SJ, et al. One-year trajectories of care 
and resource utilization for recipients of prolonged mechanical ventilation. A cohort study. Ann 
Intern Med. 2010; 153:167–75. [PubMed: 20679561] 
15. Rising KL, White LF, Fernandez WG. Emergency Department Visits After Hospital Discharge: A 
Missing Part of the Equation. Annals Emerg Med. 2013; 62(2):145–150.
16. Vashi AA, Fox JP, Carr BG, et al. Use of hospital-based acute care among patients recently 
discharged from the hospital. JAMA. 2013; 309(4):364–371. [PubMed: 23340638] 
17. Mechanic R. Post-acute care – the next frontier for controlling medicare spending. N Engl J Med. 
2014; 370(8):692–694. [PubMed: 24552315] 
18. Ashton CM, Kuykendall DH, Johnson ML, et al. The association between the quality of inpatient 
care and early readmission. Ann Intern Med. 1995; 122(6):415–421. [PubMed: 7856989] 
19. Ashton CM, Del Junco DJ, Souchek J, et al. The association between the quality of inpatient care 
and early readmission: a meta-analysis of the evidence. Med Care. 1997; 35(10):1044–1059. 
[PubMed: 9338530] 
20. Centers for Medicare & Medicaid Services. Medicare Hospital Quality Chartbook 2011: 
Performance Report on Readmission Measures for Acute Myocardial Infarction, Heart Failure, 
and Pneumonia. Washington, DC: Centers for Medicare & Medicaid Services; 2011. 
21. Lee CM, Herridge MS, Matte A, et al. Education and support needs during recovery in acute 
respiratory distress syndrome. Crit Care. 2009; 13:R153. [PubMed: 19775467] 
22. Elixhauser, A.; Steiner, C. HCUP Statistical Brief #161. Agency for Healthcare Research and 
Quality; Rockville, MD: Apr. 2013 Readmissions to U.S. hospital by diagnosis, 2010. http://
www.hcup-us.ahrq.gov/reports/statbriefs/sb153.pdf
23. Liu V, Lei X, Prescott HC, et al. Hospital readmission and healthcare utilization following sepsis 
in community settings. J Hosp Med. 201410.1002/jhm.2197
24. Prescott HC, Langa KM, Liu V, et al. Increased one-year health care utilization in survivors of 
severe sepsis. Amer J Respir Crit Care Med. 201410.1164/rccm.201403-0471OC
25. Mikkelsen ME, Miltiades AN, Gaieski DF, et al. Serum lactate is associated with mortality in 
severe sepsis independent of organ failure and shock. Crit Care Med. 2009; 37:1670–1675. 
[PubMed: 19325467] 
26. Mikkelsen ME, Gaieski DF, Goyal M, et al. Factors associated with non-adherence with early 
goal-directed therapy in the emergency department. Chest. 2010; 138:551–558. [PubMed: 
20173053] 
27. Gaieski DF, Mikkelsen ME, Band RA, et al. Impact of time to antibiotics on survival in patients 
with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the 
emergency department. Crit Care Med. 2010; 38:1045–1053. [PubMed: 20048677] 
28. Whittaker SA, Mikkelsen ME, Gaieski DF, Koshy S, Kean C, Fuchs BD. Severe sepsis cohorts 
derived from claims-based strategies appear to be biased toward a more severely ill patient 
population. Crit Care Med. 2013; 41:945–953. [PubMed: 23385099] 
Ortego et al. Page 9
Crit Care Med. Author manuscript; available in PMC 2016 April 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
29. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the 
use of innovative therapies in sepsis. Chest. 1992; 101:1644–1655. [PubMed: 1303622] 
30. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis 
Definitions Conference. Crit Care Med. 2003; 31(4):1250–1256. [PubMed: 12682500] 
31. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in 
longitudinal studies: development and validation. J Chronic Dis. 1987; 40:373–383. [PubMed: 
3558716] 
32. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: A severity of disease classification system. 
Crit Care Med. 1985; 13:818–829. [PubMed: 3928249] 
33. Dharmarajan K, et al. Diagnosis and timing of 30-day readmissions after hospitalization for heart 
failure, acute myocardial infarction, or pneumonia. JAMA. 2013; 309 (4):355–363. [PubMed: 
23340637] 
34. Donze J, Aujesky D, Williams D, et al. Potentially avoidable 30-day hospital readmissions in 
medical patients: derivation and validation of a prediction model. JAMA Intern Med. 2013; 
173(8):632–638. [PubMed: 23529115] 
35. Goldfield NI, McCullough EC, Hughes JS, et al. Identifying potentially preventable readmissions. 
Health Care Finan Review. 2008; 30(1):75–91.
36. Yende S, Angus DC. Long-term outcomes from sepsis. Curr Infect Dis Rep. 2007; 9(5):382–386. 
[PubMed: 17880848] 
37. Murugan R, Karajala-Subramanyam V, Lee M, et al. Acute kidney injury in non-severe pneumonia 
is associated with an increased immune response and lower survival. Kidney Int. 2010; 77(6):527–
535. [PubMed: 20032961] 
38. Yende S, D’Angelo G, Mayr F, et al. Elevated hemostasis markers after pneumonia increases one-
year risk of all-cause and cardiovascular deaths. PLoS One. 2011; 6(8):e22847. [PubMed: 
21853050] 
39. Yende S, D’Angelo G, Kellum JA, et al. Inflammatory markers at hospital discharge predict 
subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med. 2008; 177(11):
1242–1247. [PubMed: 18369199] 
40. Simon PM, Delude RL, Lee M, et al. Duration and magnitude of hypotension and monocyte 
deactivation in patients with community-acquired pneumonia. Shock. 2011; 36(6):553–559. 
[PubMed: 22080961] 
41. Ward PA. Immunosuppression in sepsis. JAMA. 2011; 306(23):2618–2619. [PubMed: 22187286] 
42. Yende S, Linde-Zwirble W, Mayr F, et al. Risk of cardiovascular events in severe sepsis survivors. 
Am J Respir Crit Care Med. 2014; 189(9):1065–1074. [PubMed: 24456535] 
43. Iwashyna TJ, Netzer G, Langa KM, et al. Spurious inferences about long-term outcomes: the case 
of severe sepsis and geriatric conditions. Am J Respir Crit Care Med. 2012; 185(8):835–841. 
[PubMed: 22323301] 
44. Walkey AJ, Wiener RS, Ghobrial JM, et al. Incident stroke and mortality associated with new-
onset atrial fibrillation in patients hospitalized with severe sepsis. JAMA. 2011; 306(20):2248–
2254. [PubMed: 22081378] 
45. Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Amer J of Epid. 
1993; 138:923–936.
46. Naylor MD, Brooten D, Campbell R, et al. Comprehensive discharge planning and home follow-up 
of hospitalized elders: a randomized clinical trial. JAMA. 1999; 281:613–620. [PubMed: 
10029122] 
47. Shah FA, Pike F, Alvarez K, et al. Bidirectional relationship between cognitive function and 
pneumonia. Am J Respir Crit Care Med. 2013; 188(5):586–592. [PubMed: 23848267] 
48. Iwashyna TJ. Trajectories of recovery and dysfunction after acute illness, with implications for 
clinical trial design. Am J Respir Crit Care Med. 2012; 186(4):302–304. [PubMed: 22896591] 
49. Sutton, J.; Friedman, B. HCUP Statistical Brief #161. Agency for Healthcare Research and 
Quality; Rockville, MD: Sep. 2013 Trends in septicemia hospitalizations and readmissions in 
selected HCUP states, 2005 and 2010. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb161.pdf
50. Wang T, Derhovanessian A, De Cruz S, et al. Subsequent infections in survivors of sepsis: 
epidemiology and outcomes. J Intensive Care Med. 2014; 29(2):87–95. [PubMed: 23753224] 
Ortego et al. Page 10
Crit Care Med. Author manuscript; available in PMC 2016 April 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
51. Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for 
ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003; 290(19):2588–2598. 
[PubMed: 14625336] 
52. Keller SC, Ciuffetelli D, Bilker W, et al. The impact of an infectious diseases transition service on 
the care of outpatients on parenteral antimicrobial therapy. J Pharm Tech. 2013; 29(5):205–214.
53. Schweickert WD, Pohlman MC, Pohlman AS, et al. Early physical and occupational therapy in 
mechanically ventilated, critically ill patients: a randomized, controlled trial. Lancet. 2009; 
373:1874–1882. [PubMed: 19446324] 
54. Lin CY, Barnato AE, Degenholtz HB. Physician follow-up visits after acute care hospitalization 
for elderly Medicare beneficiaries discharged to non-institutional settings. J Am Geriatr Soc. 2011; 
59(10):1947–1954. [PubMed: 21883117] 
Ortego et al. Page 11
Crit Care Med. Author manuscript; available in PMC 2016 April 01.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
Figure 1. 
Flow diagram of use of post-acute care in survivors of sepsis sepsis. * Of 79 survivors 
discharged to a skilled care facility, 25 were discharged to acute rehabilitation, 47 to a 
skilled nursing facility, and 7 to a long-term acute care hospital.
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Figure 2. 
Timing of 30-day hospital readmission in severe sepsis survivors.
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Table 1
Baseline characteristics of septic shock survivor cohort.
At-Risk Survivors (N=269)
Clinical Factors at Presentation
Age, years 59 ± 18
Female sex (n, %) 135 (50.2)
Race (n, %)
  White 112 (42.6)
  Black 144 (54.8)
  Other 7 (2.7)
Charlson Comorbidity Index 2 (1 – 3)
Illness Severity at Presentation
 Initial serum lactate (mmol/L) 4.6 (3.7 – 6.1)
 Hypotension (n, %) 184 (68.4)
 Refractory hypotension (n, %) 95 (35.3)
 Admission to ICU (n, %) 207 (77.0)
 APACHE II score 19 ± 7
 Admission to ICU (n, %) 207 (77.0)
 Mechanical ventilation use (n, %) 54 (20.1)
Source of sepsis (n, %)
 Bacteremia 27 (10.0)
 Pneumonia 50 (18.6)
 Genitourinary 57 (21.2)
 Gastrointestinal 53 (19.7)
 Skin or soft-tissue 21 (7.8)
Definition of abbreviation: APACHE=acute physiology and chronic health evaluation.
Categorical variables are presented as counts and percentages. Continuous variables are presented as means and standard deviations or median and 
interquartile ranges, as determined by their distribution.
*
Hypotension defined as systolic blood pressure ≤ 90 mm Hg. Refractory hypotension defined as systolic blood pressure ≤ 90 mm Hg after fluid 
resuscitation or use of vasoactive agents.
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Table 2
Hospital-based acute care use in 269 survivors of septic shock.
Outcomes
Hospital Readmissions
30-day hospital readmission (n, %) 63 (23.4)
60-day hospital readmission (n, %) 89 (33.1)
90-day hospital readmission (n, %) 100 (37.2)
ED Visits (Treat – and – Release Encounters)
30-day ED visit (n, %) * 14 (5.2)
Hospital-Based Acute Care Post-Discharge
30-day ED visit or readmission (n, %) 75 (27.9)†
Definition of abbreviation: ED=emergency department.
Categorical variables are reported as a count and percentage.
*
Of 56 ED encounters within 30 days, 42 (75%) led to an admission. The reasons for the 14 ED encounters not resulting in an admission were: 
cellulitis or surgical site infection (n=4), complication of a device (n=3), head injury after a fall (n=2), altered mental status (n=1), post-operative 
pain (n=1), dyspnea (n=1), gastroenteritis (n=1), and pneumonia (n=1).
†
One patient returned for a treat-and-release ED visit for altered mental status and subsequently was readmitted, both within 30 days of discharge; 
one patient was readmitted and subsequently returned for a treat-and-release ED visit for a head injury after a fall, both within 30 days. These 2 
instances explain why the sum of the ED visits and 30-day hospital readmissions do not total 75.
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Table 3
Readmission diagnoses following hospitalization for septic shock.
Readmission Diagnoses Potentially Related to Prior Sepsis Hospitalization, n(%)
Infection * 29 (46.0)
Cardiovascular and thromboembolic † 11 (17.5)
Acute kidney injury‡ 4 (6.4)
Complications of devices 2 (3.2)
Other£ 3 (4.8)
Readmission Unrelated to Prior Hospitalization
Related to comorbid condition** 14 (22.2)
Total: N = 63
*
Infectious cases included: 8 skin or soft-tissue infections (3 cellulitis cases and 5 abscess cases), 7 respiratory infections (6 pneumonia cases and 1 
empyema case), 5 gastrointestinal infections (2 new clostridium difficile cases, 2 recurrent cases, and 1 spontaneous bacterial peritonitis case), 5 
bacteremia infections (including 3 line-related cases), 2 urinary tract infections, and 2 systemic infections (one culture-negative sepsis case and one 
disseminated candidiasis case).
†
Cardiovascular and thromboembolic cases included 4 cases of venous thromboembolism, 3 cases of congestive heart failure, 1 cerebrovascular 
accident, 1 case of venous sinus thrombosis, 1 acute coronary syndrome, and 1 cardiac arrest.
‡
Acute kidney injury includes 1 case of acute interstitial nephritis due to treatment for endocarditis diagnosed during prior hospitalization and 1 
case of concomitant hypotension at time of readmission.
£
Other diagnoses include subarachnoid haemorrhage status post fall, altered mental status due to medication error, and anemia requiring 
transfusion.
**
Categorization includes 5 oncology cases readmitted for failure to thrive or chemotherapy, 2 cases of progressive liver disease, 2 cases of chronic 
pain, 1 case of malignant pericardial effusion, 1 case of gout, 1 case of nephrolithiasis, 1 case of recurrent small bowel obstruction after clostridium 
difficile enterocolitis, and 1 case of hydrocephalus requiring the placement of a shunt.
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Table 4
Patient-level factors associated with 30-day hospital readmission in survivors of septic shock.
No Readmission (N=206) Readmissions (N=63) p- value
Clinical Factors
Age, years 59 ± 18 60 ± 16 0.75
Female sex (n, %) 100 (48.5) 35 (55.6) 0.33
Race (n, %)
  White 84 (41.4) 28 (46.7)
0.74  Black 113 (55.7) 31 (51.7)
  Other 6 (3.0) 1 (1.7)
Comorbidities (n, %)
 CAD 25 (12.1) 8 (12.7) 0.90
 CHF 26 (12.6) 9 (14.3) 0.73
 Cirrhosis 7 (3.4) 6 (9.5) 0.05
 Chronic renal disease 23 (11.2) 8 (12.7) 0.74
 COPD 16 (7.8) 5 (7.9) 0.96
 Diabetes mellitus 68 (33.0) 17 (27.0) 0.37
 ESRD 16 (7.8) 4 (6.4) 0.71
 HIV 9 (4.4) 2 (3.2) 1.00
 Hypertension 95 (46.8) 31 (49.2) 0.74
 Oncology 43 (20.9) 29 (46.0) <0.001
 Transplant 29 (14.1) 8 (12.7) 0.78
Charlson Comorbidity Index 1 (1 – 3) 2 (1 – 3) 0.001
Prior hospitalization within 30 days 43 (20.9) 28 (44.4) <0.001
Illness Severity at Presentation
 Organ dysfunction
  Acute kidney injury (n, %) * 87 (42.2) 23 (36.5) 0.42
  Change in mental status 57 (27.7) 17 (27.0) 0.92
  Coagulation failure * 34 (16.5) 15 (23.8) 0.19
  Hematologic failure * 18 (8.7) 7 (11.1) 0.57
  Hepatic failure * 8 (3.9) 4 (6.4) 0.48
Hypoperfusion, lactate (mmol/L) 4.8 (4.0 – 6.3) 4.2 (2.5 – 5.3) 0.02
  Refractory hypotension 70 (34.0) 25 (39.7) 0.41
 Admission to ICU 157 (76.2) 50 (79.4) 0.60
 APACHE II score 18 ± 7 20 ± 6 0.05
ED Processes of Care
 Time to antibiotics, minutes 114 (62 – 198) 142 (81 – 224) 0.29
 Volume resuscitation, cc 3150 (2050 – 4350) 3100 (2050 – 4150) 0.44
 Transfusion (n, %) 10 (4.8) 2 (3.2) 0.57
 EGDT initiated 58 (28.2) 22 (34.9) 0.30
Source of sepsis (n, %)
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No Readmission (N=206) Readmissions (N=63) p- value
 Bacteremia 20 (9.7) 7 (11.1) 0.75
 Pneumonia 37 (18.0) 13 (20.6) 0.63
 Genitourinary 47 (22.8) 10 (15.9) 0.24
 Gastrointestinal 40 (19.4) 13 (20.6) 0.83
 Skin or soft-tissue 13 (6.3) 8 (12.7) 0.10
Hospitalization
 Hospital length of stay 6 (4 – 13) 10 (5 – 15) 0.01
 ICU length of stay† 3 (1 – 5) 2 (2 – 4) 0.32
 Mechanical ventilation use (n, %) 46 (22.3) 8 (12.7) 0.10
 PICC present at discharge 15 (7.3) 11 (17.5) 0.02
Discharge disposition
 Home 87 (42.2) 18 (28.6)
0.15 Home with home services 61 (29.6) 24 (38.1)
 Skilled care facility 58 (28.2) 21 (33.3)
Definition of abbreviation: APACHE=acute physiology and chronic health evaluation; CAD=coronary artery disease; CHF=congestive heart 
failure; COPD=chronic obstructive pulmonary disease; HIV=human immunodeficiency virus; ICU=Intensive Care Unit; PICC=peripherally-
inserted central catheter.
Categorical variables are presented as counts and percentages. Continuous variables are presented as means and standard deviations or median and 
interquartile ranges, as determined by their distribution.
*
Acute kidney injury defined as serum creatinine ≥ 0.5 mg/dL from baseline. Coagulation failure defined as international normalized ratio > 1.5 or 
PTT > 60 and hematologic failure as platelets < 100, and hepatic failure as total bilirubin > 4.0 mg/dL (25, 30). Coagulation measures and hepatic 
function measures were obtained in 78% and 90% of the cohort, respectively; when not assessed, they were presumed to be normal in accord with 
APACHE II score calculations (32). Refractory hypotension defined as systolic blood pressure ≤ 90 mm Hg after fluid resuscitation or use of 
vasoactive agents (5–7, 30).
†
ICU length of stay in subgroup of patients requiring ICU admission.
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Table 5
Clinical risk factors associated with 30-day hospital readmission in survivors of septic shock.
Independent Variable * Adjusted Odds Ratio (95% CI) p-value
Oncology 3.02 (1.60 – 5.68) 0.001
Recent hospitalization 2.26 (1.19 – 4.29) 0.01
Length of stay, > 4 days 2.18 (1.02 – 4.64) 0.04
Initial lactate levels (mmol/L) 0.89 (0.78 – 1.01) 0.07
PICC at discharge 1.68 (0.66 – 4.25) 0.27
Definition of abbreviation: CI=confidence interval; PICC=peripherally-inserted central catheter.
*
An adjusted odds ratio of greater than 1 represents an increased risk of 30-day hospital readmission. The potential confounder, year of admission, 
was neither associated with the dependent variable nor did its inclusion alter the odds ratios of any of the candidate risk factors significantly. 
Conversely, a recent hospitalization attenuated the association between length of stay and 30-day readmission significantly.
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